metapsy-project/data-depression-psiloctr: Version 25.1.0
Zenodo (CERN European Organization for Nuclear Research)Β β November 16, 2025
Source: OpenAlex
Summary
A groundbreaking **data collection** effort now offers unprecedented insights into psilocybin's potential for treating depression. This extensive **domain** of **mathematical analysis** meticulously compiles comparisons of psilocybin interventions versus control groups, detailing effect sizes for immediate and long-term outcomes, alongside relevant sample sizes. Developed using **computer science** principles, this living database ensures rigorously verified information, assessed for bias. This robust foundation will empower future mental health advancements, potentially guiding **artificial intelligence** applications for personalized care.
Abstract
The data-depression-psiloctr dataset π The data-depression-psiloctr dataset is a meta-analytic research domain (MARD) on psilocybin-assisted therapies for adults with depressive symptoms. This MARD is part of the Metapsy project. The date of the last search update is provided here. This dataset includes psilocybin-assisted therapy vs. control ('psy vs ctr') comparisons. Effect sizes are provided for outcomes at post-test and long-term follow-ups, if available. This living database has been developed by the Sypres (Synthesis of Psychedelic Research Studies) Collaboration. Further information on Sypres and its underlying methodology can be found in this published article. The dataset follows the Metapsy data standard. All included information has been independently extracted two researchers. Risk of bias ratings were conducted using the Cochrane Collaboration Risk of Bias Tool (Version 2).